เว็บไซต์คืออะไร?

http://www.GreenCultureLabs-Thailand.com/

Green Culture Labs co., Ltd, Amphoe Wat Bot (2026)

24/04/2026

Once weapons were manufactured to fight wars, now wars are manufactured to sell weapons"
— Arundhati Roy

James Madison identified war as the ultimate threat to liberty, noting it drives the creation of armies, debts, and taxes, which together serve as instruments for the few to rule the many.

24/04/2026

Effects of Japanese Green Tea on the Brain: Focus on Anti-Aging
Journal: Brain and Nerve (2026)

✔️ Core Idea

Japanese green tea is not just a plant extract. It is a precision-cultivated, multi-compound system where agricultural control directly shapes compounds that support human brain health and longevity.

✔️ Key Active Compounds

• Catechins (especially EGCG) – strong antioxidants

• L-theanine – promotes relaxation and cognitive balance

• Caffeine – mild stimulant improving alertness

• Other polyphenols – neuroprotective and anti-inflammatory

✔️ Main Findings

1. Neuroprotection (Brain Cell Protection)

• Reduces oxidative stress (major driver of brain aging)

• Protects neurons from degeneration and cellular damage

2. Anti-Aging Effects

• Slows cognitive decline associated with aging

• Linked to lower risk of neurodegenerative diseases

3. Cognitive Function

• Improves attention, memory, and clarity

• L-theanine + caffeine → balanced focus without overstimulation

4. Mechanisms of Action

• Antioxidant activity → neutralizes free radicals

• Anti-inflammatory pathways → reduce brain inflammation

• Neurotransmitter modulation → improves signaling

• May influence amyloid-beta accumulation

5. Long-Term Consumption

• Regular intake linked to better brain health

• Benefits accumulate over time with consistent use

✔️ Advanced Quality Control & Cultivation Science

Japanese green tea quality is not accidental. It is engineered through controlled plant stress and precision agriculture:

• Shading techniques (e.g., matcha, gyokuro)
→ Increase L-theanine and amino acids
→ Reduce bitterness, enhance calm-focus effects

• Light stress regulation
→ Drives catechin (EGCG) production as plant defense

• Nutrient and soil control
→ Optimizes nitrogen → boosts amino acid synthesis

• Harvest timing (young leaves)
→ Higher bioactive compound density

• Processing control (steaming vs oxidation)
→ Preserves catechins and prevents degradation

These are intentional stress signals that activate plant defense pathways
→ resulting in higher concentrations of compounds beneficial to humans

✔️ Plant–Human Relationship (Critical Insight)

• Plants produce protective chemicals to survive environmental stress
• Humans consume those same molecules for protection and adaptation

This creates a biological alignment:

• Plant stress → produces bioactives

• Human consumption → gains resilience, neuroprotection, longevity

✔️ System-Level Perspective

• Agriculture = upstream pharmacology

• Cultivation stress = biochemical signal engineering

• Quality control = consistency of human outcomes

✔️ Bottom Line

Japanese green tea represents a closed-loop system between nature and human biology:

• Controlled cultivation → optimized phytochemistry
• Optimized phytochemistry → measurable human health benefits

It is not just a beverage.
It is a precision botanical system where plant survival chemistry becomes human performance and longevity support.

April 2026
Source Here ⬇️

https://webview.isho.jp/journal/detail/abs/10.11477/mf.188160960780040375

23/04/2026

Living your best life your way.

Live-Streaming the Sativa Style.

23/04/2026

G***a Global Markets Projection
Rapid Expansion From $65.1 Billion In 2024 To $319.5 Billion By 2034.

✔️ Global Market Growth

• $65.1B (2024) → $319.5B (2034)

• ~5× expansion in 10 years

• ~17.2% CAGR

✔️ Industry Scope

• Medical cannabis (pharma pathways)

• Recreational markets

• CBD wellness products

• Industrial h**p (materials, textiles)

• Extracts, isolates, APIs

✔️ Geographic Trends

• North America leads (mature market)

• Europe fastest regulatory growth

• Asia-Pacific emerging, high upside

• Latin America & Africa as low-cost producers

✔️ Growth Drivers

• Expanding legalization globally

• Rising medical and therapeutic demand

• Consumer shift to plant-based products

• Increased pharma and biotech involvement

• Product innovation (edibles, beverages, formulations)

✔️ Industry Evolution

• Illicit → regulated markets
• Raw plant → standardized extracts

• Informal trade → GMP / pharma-grade systems

✔️ Strategic Insight

• Value shifting from cultivation → processing and extraction

• Compliance, QC, and data becoming critical

• High-margin segments: APIs, isolates, formulations

✔️ Bottom Line

• Cannabis becoming a global, regulated multi-industry platform

• Transitioning into healthcare, wellness, and biotech infrastructure

G***a Goes Global

From prohibition to progress, plants are returning as tools for public health and global innovation.

Green Culture Labs co., Ltd
Beneficial Botanicals RnD

Cannabis - Mytragyna Speciosa (Kratom) - Psychedelics Research and Development: Thailand

April 22, 2026
Full Article in Comments

—————————————————
DISCLAIMER: All shared content is for Awareness, Academic, and Discussion Purposes Only.

This page does not provide Medical Advice, Endorse Specific Treatments and/or Substances NOT legally Approved by Public Health Authorities / Agencies in your Region(s)

Content Consists of Most Up to Date News Articles - Scientific Summaries on People and Planet

18+ ONLY | Viewers Discretion is Advised

Join Growing Community Raising Awareness, Increase Educational Capacity, and High iQ-uality Discussions

Gain Valuable Knowledge Join Growing Community Here ⬇️ Review
Green Culture Labs co., Ltd
Green Culture Labs co., Ltd

REACT - RESHARE - REEDUCATE

22/04/2026

G***a Global Markets Projection
Rapid Expansion From $65.1 Billion In 2024 To $319.5 Billion By 2034.

✔️ Global Market Growth

• $65.1B (2024) → $319.5B (2034)

• ~5× expansion in 10 years

• ~17.2% CAGR

✔️ Industry Scope

• Medical cannabis (pharma pathways)

• Recreational markets

• CBD wellness products

• Industrial h**p (materials, textiles)

• Extracts, isolates, APIs

✔️ Geographic Trends

• North America leads (mature market)

• Europe fastest regulatory growth

• Asia-Pacific emerging, high upside

• Latin America & Africa as low-cost producers

✔️ Growth Drivers

• Expanding legalization globally

• Rising medical and therapeutic demand

• Consumer shift to plant-based products

• Increased pharma and biotech involvement

• Product innovation (edibles, beverages, formulations)

✔️ Industry Evolution

• Illicit → regulated markets
• Raw plant → standardized extracts

• Informal trade → GMP / pharma-grade systems

✔️ Strategic Insight

• Value shifting from cultivation → processing and extraction

• Compliance, QC, and data becoming critical

• High-margin segments: APIs, isolates, formulations

✔️ Bottom Line

• Cannabis becoming a global, regulated multi-industry platform

• Transitioning into healthcare, wellness, and biotech infrastructure

G***a Goes Global

From prohibition to progress, plants are returning as tools for public health and global innovation.

Green Culture Labs co., Ltd
Beneficial Botanicals RnD

Cannabis - Mytragyna Speciosa (Kratom) - Psychedelics Research and Development: Thailand

April 22, 2026
Full Article in Comments

—————————————————
DISCLAIMER: All shared content is for Awareness, Academic, and Discussion Purposes Only.

This page does not provide Medical Advice, Endorse Specific Treatments and/or Substances NOT legally Approved by Public Health Authorities / Agencies in your Region(s)

Content Consists of Most Up to Date News Articles - Scientific Summaries on People and Planet

18+ ONLY | Viewers Discretion is Advised

Join Growing Community Raising Awareness, Increase Educational Capacity, and High iQ-uality Discussions

Gain Valuable Knowledge Join Growing Community Here ⬇️ Review
Green Culture Labs co., Ltd

REACT - RESHARE - REEDUCATE

21/04/2026

Trump Administration (American Government) signed Executive Orders for both Cannabis and now Psychedelics.

Culture - Custom - History

Respect for Plants and People

Psilocybin, Ibogaine, M**A, and L*D all trace back to Indigenous plant knowledge and ceremonial use for centuries.

The extraction problem. Every substance named in this order — psilocybin from mushrooms, ibogaine from the iboga plant of the Bwiti tradition in Gabon, even the synthetic lineage of M**A and L*D — traces back to plant knowledge and ceremonial use held by Indigenous peoples for centuries or millennia.

The order channels these into a pharmaceutical-regulatory pipeline (FDA approval, clinical trials, patentable formulations) without a single word acknowledging the people who have been stewarding these medicines.

The commercialization risk. By accelerating FDA approval and inviting private-sector collaboration, the order essentially opens the door for pharmaceutical companies to patent synthetic versions or delivery mechanisms of compounds that Indigenous peoples have used as sacraments.

This is a familiar pattern — biopiracy dressed in clinical language. Once a company holds a patent on a psilocybin formulation or an ibogaine derivative, Indigenous communities could find themselves legally restricted from accessing or distributing the very medicines they've tended for generations.

Pe**te and ayahuasca are invisible. The order focuses on substances with commercial pharmaceutical potential. It says nothing about pe**te.

This silence is telling — these are the medicines most deeply embedded in living Indigenous ceremonial practice, and they're left in the same Schedule I limbo.

The order helps the substances that can be commodified and ignores the ones that are inseparable from living cultures.

The sovereignty gap. There is no mention of tribal consultation, no recognition of tribal sovereignty over traditional plant medicine knowledge, and no framework for benefit-sharing or prior informed consent — principles that exist in international law (the Nagoya Protocol, the UN Declaration on the Rights of Indigenous Peoples) precisely because of centuries of extraction from Indigenous knowledge systems.

The veterans framing cuts both ways. Many Indigenous veterans stand to benefit from expanded psychedelic therapy access — Native Americans serve in the military at higher per-capita rates than any other group and face disproportionate PTSD rates.

But the order routes that access through Western clinical frameworks rather than supporting the ceremonial healing traditions that Indigenous veterans' own communities already hold.

In short: this order takes plant medicines that Indigenous peoples have protected, often at great legal and personal cost, and accelerates their absorption into a pharmaceutical system that has historically excluded, criminalized, and failed to compensate those same peoples.

The opening for healing is real, but without explicit protections for Indigenous sovereignty, religious freedom, traditional knowledge, and equitable benefit-sharing, this order risks repeating one of the oldest patterns in colonial history — taking the medicine and leaving behind the people who made it sacred.

Credit to:
— Sandor Iron Rope�Cultural Outreach

This applies to many past and present Prohibited Plants from Traditional and Ancient Cultures.

Prohibit the Plant to Patent its Molecule. Big Pharma Play Book

It’s often stated that History does not repeat itself (it sure seems so) but often rhymes.

REACT - RESHARE to REEDUCATE

Green Culture Labs co., Ltd
Green Culture Labs co., Ltd

We appreciate our community more than words can ever express. Green Culture Labs exists only because of your support, trust, and shared belief in what we are building together.

Thank you
Respectfully,
Truong M Nguyen

21/04/2026

Trump Administration (American Government) signed Executive Orders for both Cannabis and now Psychedelics.

Culture - Custom - History

Respect for Plants and People can eliminate many Problems

Psilocybin, Ibogaine, M**A, and L*D all trace back to Indigenous plant knowledge and ceremonial use for centuries.

The extraction problem. Every substance named in this order — psilocybin from mushrooms, ibogaine from the iboga plant of the Bwiti tradition in Gabon, even the synthetic lineage of M**A and L*D — traces back to plant knowledge and ceremonial use held by Indigenous peoples for centuries or millennia.

The order channels these into a pharmaceutical-regulatory pipeline (FDA approval, clinical trials, patentable formulations) without a single word acknowledging the people who have been stewarding these medicines.

The commercialization risk. By accelerating FDA approval and inviting private-sector collaboration, the order essentially opens the door for pharmaceutical companies to patent synthetic versions or delivery mechanisms of compounds that Indigenous peoples have used as sacraments.

This is a familiar pattern — biopiracy dressed in clinical language. Once a company holds a patent on a psilocybin formulation or an ibogaine derivative, Indigenous communities could find themselves legally restricted from accessing or distributing the very medicines they've tended for generations.

Pe**te and ayahuasca are invisible. The order focuses on substances with commercial pharmaceutical potential. It says nothing about pe**te.

This silence is telling — these are the medicines most deeply embedded in living Indigenous ceremonial practice, and they're left in the same Schedule I limbo.

The order helps the substances that can be commodified and ignores the ones that are inseparable from living cultures.

The sovereignty gap. There is no mention of tribal consultation, no recognition of tribal sovereignty over traditional plant medicine knowledge, and no framework for benefit-sharing or prior informed consent — principles that exist in international law (the Nagoya Protocol, the UN Declaration on the Rights of Indigenous Peoples) precisely because of centuries of extraction from Indigenous knowledge systems.

The veterans framing cuts both ways. Many Indigenous veterans stand to benefit from expanded psychedelic therapy access — Native Americans serve in the military at higher per-capita rates than any other group and face disproportionate PTSD rates.

But the order routes that access through Western clinical frameworks rather than supporting the ceremonial healing traditions that Indigenous veterans' own communities already hold.

In short: this order takes plant medicines that Indigenous peoples have protected, often at great legal and personal cost, and accelerates their absorption into a pharmaceutical system that has historically excluded, criminalized, and failed to compensate those same peoples.

The opening for healing is real, but without explicit protections for Indigenous sovereignty, religious freedom, traditional knowledge, and equitable benefit-sharing, this order risks repeating one of the oldest patterns in colonial history — taking the medicine and leaving behind the people who made it sacred.

Credit to:
— Sandor Iron Rope�Cultural Outreach

This applies to many past and present Prohibited Plants from Traditional and Ancient Cultures.

Prohibit the Plant to Patent the Molecule.

It’s often stated that History does not repeat itself (it sure seems so) but often rhymes.

REACT - RESHARE to REEDUCATE

Green Culture Labs co., Ltd

We appreciate our community more than words can ever express. Green Culture Labs exists only because of your support, trust, and shared belief in what we are building together.

Thank you
Respectfully,
Truong M Nguyen

20/04/2026

“Look deep into nature, and then you will understand everything better.”
— Albert Einstein

"He who plants a tree plants hope.”
— Lucy Larcom

20/04/2026

Thailand’s relationship with plant medicines is one of the most dramatic policy reversals in modern history.

A country’s most Prohibited Plants

✔️ Traditional Roots - Culture and Tradition: Thailand

• Cannabis and Kratom (Mitragyna Speciosa) were used for centuries in Thai Traditional Medicine

• Employed for pain relief, fatigue, digestion, diabetes, diarrhea, mental alertness and daily labor support

• Integrated into rural life as medicinal herbs, not treated as criminal substances

✔️ War on Drugs Era (1970s–2000s) Before and After

• Thailand banned Kratom in 1943 primarily to protect government o***m tax revenue, as widespread local use reduced demand for taxed o***m under the state monopoly system.

• Cannabis and Kratom classified as category 5 narcotics under strict laws

• Harsh and Deadly enforcement escalated into the early 2000s anti-drug campaign

• Thousands of extrajudicial killings and mass incarcerations

• Policies widely criticized internationally for human rights violations

✔️ Shift Toward Reform (2018–2021)

• 2018: Thailand becomes first in Asia to legalize medical cannabis

• 2021: Kratom removed from the narcotics list after decades of prohibition

• Recognition that traditional plants should not be treated like synthetic drugs

• Regulate Plants as Plants and Chemical Compounds not naturally produced in plants categorized as new drug development

✔️ Decriminalization and Public Access (2022)

• 2022 June Cannabis was removed from Category 5 narcotics

• 1000s of prisoners freed from Thai jails who were convicted of cannabis related offenses. Including distribution and cultivation. (video and articles in comments)

• Rapid emergence of cultivation, retail, and research sectors

• Universities, Hospitals, and private sector begin formal R&D

• Policy driven by public demand, economic opportunity, and health access

✔️ Emerging Frontier: Psychedelic Research

• Early-stage discussions around psilocybin and other psychedelic compounds

• Focus on controlled research frameworks, not open commercialization

• Reflects global shift toward evidence-based mental health therapies

✔️ What This Represents

• A population-driven correction of past policy extremes

• Rebalancing public health, cultural tradition, and economic growth

• From Prohibition and Punishment > to Regulation and Research > Stigma to Science

Thailand did not just legalize / decriminalize plants
It redefined its relationship with them.

“Look deep into nature, and then you will understand everything better.”
— Albert Einstein

Happy 4/20 🌿 not just a date, but a reminder of those and what came before us that made what we have today possible

REACT - RESHARE - REEDUCATE

Green Culture Labs co., Ltd

Green Culture Labs co., Ltd

19/04/2026

Triacontanol + Precision Fertigation Improves Cannabis Compounds, Quantity and Quality

✔️ Old Compound, New Application

• Triacontanol studied for ~40–50 years in agriculture

• Natural plant growth regulator that enhances photosynthesis, yield, and secondary metabolite production

• Now applied to high-value cannabis cultivation for yield + chemical control

✔️ Study Insight

• Optimized NPK fertigation + triacontanol significantly improved plant performance

✔️ Yield Increase

• ~10% to 30% higher flower yield vs control

✔️ Volatile Compounds

• Increased terpene concentration per gram

• Stronger aroma and clearer chemotype expression

✔️ Mechanism

• Boosts photosynthesis and carbon fixation

• Increases metabolic precursors for cannabinoids and terpenes

✔️ Key Takeaway

• Not just bigger plants

• Controlled, higher-quality phytochemical output

✔️ Implication

• Cultivation inputs can directly shape final chemistry

• Critical for standardized, pharmaceutical-grade botanical production

• Genetic engineering, selective breeding, precision fertigation, biostimulants, environmental control, and data-driven cultivation enable control of active compound’s quantity, quality, and consistency for pharmaceutical-grade botanical inputs.

Cannabis - Kratom (Mitragyna Speciosa) - Psychedelics

Beneficial Botanicals Derived Drugs RnD: Thailand 🇹🇭

SOURCE / Link 🔗 HERE ⬇️

Altered NPK Fertigation With Triacontanol Supplementation Indicates Promising Improvements to Cannabis Flower Yield and Volatile Composition

Published Date:
March 2026

https://rsnz.onlinelibrary.wiley.com/doi/pdf/10.1002/nzc2.70167

REACT - RESHARE - REEDUCATE

GREEN CULTURE LABS CO., LTD
Green Culture Labs co., Ltd

18/04/2026

Ma*****na Is Safer Than McDonald’s French Fries, Cory Booker Says.

Published on April 17, 2026
By Tom Angell
At: Ma*****na Moment

One of the senators leading the fight to legalize ma*****na in Congress joked that the federal government might need to step in and enact restrictions on a more addictive substance: french fries from McDonald’s.

Sen. Cory Booker (D-NJ), who has sponsored several bills to remove cannabis from the Controlled Substances Act (CSA), said that “I am the leader in the Senate for descheduling ma*****na, but we should schedule McDonald’s french fries.”

“I don’t know what they put on them,” he said. “I think it is an illegal substance.”

CBD Can Help Treat Pain, Cancer, Schizophrenia, COVID And Other Conditions

The senator’s comments came at an event late last month where he was promoting his new book, “Stand.”

Booker was telling a story about his relationship with his driver, who has been with him since he served as mayor of Newark, New Jersey.

“We’ve been in the car together for, God, 20 years, and we don’t have to speak to each other.

He can just look in the rearview mirror and sense that I’m in one of those moments where I’ve got to do work, I got to read documents, whatever,” Booker said.

“And so he, as we get ready to pass this McDonald’s, he looks in the rearview mirror and immediately, quickly, lurches into the drive through because he, using his telepathic powers, looked in the rearview mirror and saw the look of shame on my face, and he knew that I needed — physical addiction here — I needed some McDonald’s french fries.”

Which Golden Arcs would you prefer? Turn that frown upside down… Go G***a !

April 17, 2026
Full Article in comments

https://www.ma*****namoment.net/ma*****na-is-safer-than-mcdonalds-french-fries-cory-booker-says/

16/04/2026

Cannabis sativa Linn: A Medicinal Plant with Promising Muscle Relaxant-related Constituents

• This review examines cannabis compounds for managing musculoskeletal conditions such as arthritis, fibromyalgia, low back pain, and inflammation

• Current treatments like NSAIDs and opioids provide short term relief but are limited by toxicity, dependency, and safety risks

• This drives demand for safer plant derived alternatives targeting multiple pathways

✔️ Cannabis contains a large therapeutic chemical library

• Over 500 compounds identified

• ~125 cannabinoids, ~120 terpenes, ~45 phenolics, plus flavonoids and minor alkaloids

• Key cannabinoids
• CBD, Δ9 THC, CBG, CBC, CBN

• Emerging compounds
• Δ9 THCP, Δ9 THCB, CBDH

• Key terpenes
• β caryophyllene, β myrcene, limonene, α pinene, linalool

✔️ Multi compound pharmacology is central

• Cannabis works through multiple compounds acting together on pain, inflammation, and muscle tension

• Not a single molecule effect but a network pharmacology system

✔️ Mechanism of action

• CB1 receptors in brain and spinal cord regulate pain signaling and muscle relaxation

• CB2 receptors in immune system reduce inflammation and cytokine activity

• Cannabinoids inhibit cAMP and MAPK pathways linked to pain and inflammation

• Additional targets such as TRPV1 may contribute

✔️ Key functional effects by compound class

• CBD
• Anti inflammatory, analgesic, anti arthritis, relaxation promoting

• Δ9 THC
• Analgesic, anti inflammatory, antinociceptive, muscle relaxing

• CBG, CBC, CBN
• Contribute to analgesic and anti inflammatory effects

• Terpenes
• β myrcene supports muscle relaxation
• β caryophyllene and limonene support anti inflammatory activity

✔️ Structure activity relationship is a major insight

• Small structural changes significantly alter potency

• C3 alkyl side chain length directly impacts receptor binding

• Δ9 THCP with a longer side chain shows ~33 times higher CB1 affinity than Δ9 THC

• Δ9 THCB acts as a partial CB1 agonist with analgesic effects

• CBDH shows analgesic activity and may act beyond CB receptors

✔️ Biosynthesis and processing matter

• Cannabinoids are produced in trichomes as acidic forms such as THCA and CBDA

• Heat, light, and aging convert them into active neutral forms

• Critical for extraction, stability, and quality control

✔️ Key takeaway

• Cannabis is a multi compound pharmacological system with real potential for muscle relaxation, pain, and inflammation

• Future therapies may come from optimized cannabinoids like THCP, THCB, and CBDH combined with terpene synergy

• Further toxicology and clinical studies are needed to translate this into safe and effective medicines

✔️ Closing

• This study reinforces that Cannabis sativa is not just a traditional remedy but a scientifically valuable platform for next generation musculoskeletal therapeutics

Added Note and SOURCE HERE:

April 10, 2026

Naturally occurring in Cannabis sativa from study:
• CBD
• Δ9 THC
• CBG
• CBC
• CBN
• Terpenes such as β caryophyllene, myrcene, limonene, α pinene, linalool
• These are produced directly by the plant in trichomes

Naturally occurring but in very low concentrations:
• Δ9 THCP
• Δ9 THCB
• CBDH
• These have been identified in cannabis but typically at trace levels

Often isolated, enriched, or studied after modification:

• While THCP, THCB, and CBDH exist naturally, most research uses isolated or synthesized versions due to low natural abundance

• Structural analogs and derivatives are often semi synthetic or lab optimized to study potency and receptor binding

Important distinction:

• “Natural” refers to presence in the plant

• “Practical use” often involves extraction, purification, or synthesis to reach meaningful doses

• The core cannabinoids and terpenes are fully natural plant compounds

• The newer high potency cannabinoids are naturally inspired but often lab produced for research and development scale

Cannabis is a molecular gold mine, containing hundreds of bioactive compounds with diverse therapeutic potential for pain, inflammation, neurological, and metabolic disorders.

Is this why a natural plant with potent compounds to potentially deal with diseases rather than suppressing symptoms has been Stigmatized and Criminalized?

Link 🔗 Here

https://journals.sagepub.com/doi/epub/10.1177/22313354261436144

April 10, 2026
Full Open Access Article and Added Information in comments.

REVIEW - REACT - RESHARE - REEDUCATE
Green Culture Labs co., Ltd

Green Culture Labs co., Ltd

24/04/2026

24/04/2026

23/04/2026

23/04/2026

22/04/2026

21/04/2026

21/04/2026

20/04/2026

20/04/2026

19/04/2026

18/04/2026

16/04/2026

ที่อยู่

เว็บไซต์

แจ้งเตือน

ทางลัด

แชร์

ประเภท